WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

In winter, various respiratory infectious diseases such as influenza (flu), pneumonia, and COVID-19 are prevalent at the same ...

Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift ...

COVID-19 infections are rising again across the U.S. Here's which symptoms to look for and how to protect yourself over the ...

TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA1positive ...

IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.

Learn more about whether AtriCure, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

So, QuidelOrtho is making some big moves in the diagnostics world, and a lot of it has to do with a company called LEX Diagnostics. It seems like they’re really trying to speed things up, especially ...

The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...